News
News
From December 12th to 14th, 2023, CEO Shunichi Kashida delivered a keynote speech and participated in a panel discussion at the 6th RNA-Targeted Drug Discovery & Development Summit in Boston.
Presentation Title: Comprehensive Interactome Profiling of RNA Library vs Compound Library Identifies Selective RNA Binders
Panel Discussion Title: What Makes a ‘Good’ RNA Target?